Biotechnology
FDA warns some Tydemy birth control pills may not be effective, could result in unexpected pregnancy
Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration has warned that some Tydemy birth control pills may not be effective, several days after the manufacturer recalled two batches of the medication that were distributed in […]
Read More
Humana shares rise after insurer says medical costs came in lower than expected
A Humana office in Louisville, Kentucky, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. The results ease investor concerns two months after Humana and rival UnitedHealth Group warned that a surge in […]
Read More
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine. GSK claims Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen used in its own shot. related investing news “Upon information and belief, Pfizer knowingly […]
Read More
CVS beats on earnings and revenue as the company slashes costs
A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug. 2, 2019. Michael Short | Bloomberg | Getty Images CVS Health on Wednesday reported second-quarter earnings and revenue that beat expectations, as the company slashes costs and lays off thousands of employees. CVS has implemented a cost-cutting program as it […]
Read More
Walgreens is now offering RSV vaccines for older adults
Respiratory syncytial virus viral vaccine under research. Hailshadow | Istock | Getty Images Walgreens is now offering the respiratory syncytial virus vaccine for older adults nationwide, the pharmacy chain said on Tuesday. People ages 60 and older can schedule an appointment this week through Walgreens’ app, website, by phone or by visiting their local pharmacy. […]
Read More
CVS to slash 5,000 jobs as company deepens costly health care push
A woman walks past a CVS Pharmacy in Washington, DC, on November 2, 2022. Brendan Smialowski | AFP | Getty Images CVS Health is cutting 5,000 jobs to reduce costs as the retail pharmacy giant furthers its push into health care offerings, a person familiar with the matter told CNBC on Tuesday. The pharmacy chain […]
Read More
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a quarterly loss, however, due to charges associated with the company’s acquisition of Prometheus Biosciences earlier this year. related investing news Merck swung to a net loss of $5.98 […]
Read More
Pfizer beats on earnings, but revenue misses as Covid product sales plummet
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that fell short of estimates as Covid product sales plunged. Pfizer reported second-quarter sales of $12.73 billion, down 54% over the same period a year ago. Excluding sales of the company’s Covid vaccine […]
Read More
NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies
Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. There […]
Read More
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their sleeves and take one. That’s largely because pandemic fatigue, the belief that […]
Read More